{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:47:53Z","timestamp":1790729273189,"version":"4.1.0"},"reference-count":27,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2020,1,6]]},"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n                  <jats:title>Backgrounds<\/jats:title>\n                  <jats:p>The incidence of germline mutations in the newly discovered cryptic exon (E1\u2019) of <jats:italic>VHL<\/jats:italic> gene in patients with von Hippel-Lindau (VHL) disease and in patients with paraganglioma or pheochromocytoma (PPGL) is not currently known.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We studied a large international multicentre cohort of 1167 patients with a previous negative genetic testing. Germline DNA from 75 patients with a single tumour of the VHL spectrum (\u2018Single VHL tumour\u2019 cohort), 70 patients with multiple tumours of the VHL spectrum (\u2018Multiple VHL tumours\u2019 cohort), 76 patients with a VHL disease as described in the literature (\u2018VHL-like\u2019 cohort) and 946 patients with a PPGL were screened for E1\u2019 genetic variants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Six different genetic variants in E1' were detected in 12 patients. Two were classified as pathogenic, 3 as variants of unknown significance and 1 as benign. The rs139622356 was found in seven unrelated patients but described in only 16 patients out of the 31 390 of the Genome Aggregation Database (p&lt;0.0001) suggesting that this variant might be either a recurrent mutation or a modifier mutation conferring a risk for the development of tumours and cancers of the VHL spectrum.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>\n                     <jats:italic>VHL<\/jats:italic> E1\u2019 cryptic exon mutations contribute to 1.32% (1\/76) of \u2018VHL-like\u2019 cohort and to 0.11% (1\/946) of PPGL cohort and should be screened in patients with clinical suspicion of VHL, and added to panels for Next Generation Sequencing (NGS) diagnostic testing of hereditary PPGL. Our data highlight the importance of studying variants identified in deep intronic sequences, which would have been missed by examining only coding sequences of genes\/exomes. These variants will likely be more frequently detected and studied with the upcoming implementation of whole-genome sequencing into clinical practice.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jmedgenet-2019-106519","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T17:15:26Z","timestamp":1580318126000},"page":"752-759","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Germline mutations in the new E1\u2019 cryptic exon of the <i>VHL<\/i> gene in patients with tumours of von Hippel-Lindau disease spectrum or with paraganglioma"],"prefix":"10.1136","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4742-2708","authenticated-orcid":false,"given":"Alexandre","family":"Buffet","sequence":"first","affiliation":[{"name":"Universit\u00e9 de Paris, PARCC, INSERM, Equipe Labellis\u00e9e par la Ligue contre le Cancer, F-75015, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Calsina","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; and Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahida","family":"Flores","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Department of Medicine, Mays Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Giraud","sequence":"additional","affiliation":[{"name":"Genetics Department, Hospices Civils de LYON (HCL), University Hospital, East Biology and Pathology Center, B-A3, 59 Bld Pinel, 69677, Bron, France"},{"name":"R\u00e9seau National pour Cancers Rares PREDIR labellis\u00e9 par l\u2019Institut National contre le Cancer, H\u00f4pital Bic\u00eatre, Assistance Publique-H\u00f4pitaux de Paris, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Lenglet","sequence":"additional","affiliation":[{"name":"\u00c9cole Pratique des Hautes \u00c9tudes, PSL Research University, Paris, France"},{"name":"L'Institut du Thorax, INSERM, Centre National de la Recherche Scientifique (CNRS), Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Romanet","sequence":"additional","affiliation":[{"name":"Aix Marseille Univ, APHM, INSERM, MMG, Laboratory of Molecular Biology Hospital La Conception, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Deflorenne","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, PARCC, INSERM, Equipe Labellis\u00e9e par la Ligue contre le Cancer, F-75015, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Aller","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition Service. Hospital Universitario Puerta de Hierro, 28222, Majadahonda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bourdeau","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Centre de recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Bressac-de Paillerets","sequence":"additional","affiliation":[{"name":"R\u00e9seau National pour Cancers Rares PREDIR labellis\u00e9 par l\u2019Institut National contre le Cancer, H\u00f4pital Bic\u00eatre, Assistance Publique-H\u00f4pitaux de Paris, Le Kremlin-Bic\u00eatre, France"},{"name":"Gustave Roussy, Universit\u00e9 Paris-Saclay, D\u00e9partement de Biopathologie and INSERM U1186, Villejuif, F-94805, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Calatayud","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nutrition, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Dehais","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pitaux Universitaires La Piti\u00e9 Salp\u00eatri\u00e8re-Charles Foix, Service de Neurologie 2-Mazarin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"De Mones Del Pujol","sequence":"additional","affiliation":[{"name":"Service ORL, H\u00f4pital Pellegrin, CHU de Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atanaska","family":"Elenkova","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, USHATE \u201cAcad. Ivan Penchev\u201d, Medical University Sofia, Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Herman","sequence":"additional","affiliation":[{"name":"Assistance Publique, H\u00f4pitaux de Paris, Service ORL-CCF, h\u00f4pital Lariboisi\u00e8re, universit\u00e9 Paris VII, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kamenick\u00fd","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital de Bic\u00eatre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de R\u00e9f\u00e9rence des Maladies Rares de l'Hypophyse, Le Kremlin Bicetre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lejeune","sequence":"additional","affiliation":[{"name":"R\u00e9seau National pour Cancers Rares PREDIR labellis\u00e9 par l\u2019Institut National contre le Cancer, H\u00f4pital Bic\u00eatre, Assistance Publique-H\u00f4pitaux de Paris, Le Kremlin-Bic\u00eatre, France"},{"name":"Department of Clinical Genetics, Centre Hospitalier R\u00e9gional et Universitaire de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Louis","family":"Sadoul","sequence":"additional","affiliation":[{"name":"Service d'Endocrinologie, H\u00f4pital de L'Archet, CHU de Nice, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Barlier","sequence":"additional","affiliation":[{"name":"R\u00e9seau National pour Cancers Rares PREDIR labellis\u00e9 par l\u2019Institut National contre le Cancer, H\u00f4pital Bic\u00eatre, Assistance Publique-H\u00f4pitaux de Paris, Le Kremlin-Bic\u00eatre, France"},{"name":"Aix Marseille Univ, APHM, INSERM, MMG, Laboratory of Molecular Biology Hospital La Conception, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Richard","sequence":"additional","affiliation":[{"name":"R\u00e9seau National pour Cancers Rares PREDIR labellis\u00e9 par l\u2019Institut National contre le Cancer, H\u00f4pital Bic\u00eatre, Assistance Publique-H\u00f4pitaux de Paris, Le Kremlin-Bic\u00eatre, France"},{"name":"\u00c9cole Pratique des Hautes \u00c9tudes, PSL Research University, Paris, France"},{"name":"G\u00e9n\u00e9tique Oncologique EPHE, INSERM U1186, Gustave Roussy Cancer Campus, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Favier","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, PARCC, INSERM, Equipe Labellis\u00e9e par la Ligue contre le Cancer, F-75015, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Burnichon","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, PARCC, INSERM, Equipe Labellis\u00e9e par la Ligue contre le Cancer, F-75015, Paris, France"},{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou, Service de G\u00e9n\u00e9tique, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Gardie","sequence":"additional","affiliation":[{"name":"\u00c9cole Pratique des Hautes \u00c9tudes, PSL Research University, Paris, France"},{"name":"L'Institut du Thorax, INSERM, Centre National de la Recherche Scientifique (CNRS), Universit\u00e9 de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia L","family":"Dahia","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Department of Medicine, Mays Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Robledo","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; and Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Paule","family":"Gimenez-Roqueplo","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, PARCC, INSERM, Equipe Labellis\u00e9e par la Ligue contre le Cancer, F-75015, Paris, France"},{"name":"R\u00e9seau National pour Cancers Rares PREDIR labellis\u00e9 par l\u2019Institut National contre le Cancer, H\u00f4pital Bic\u00eatre, Assistance Publique-H\u00f4pitaux de Paris, Le Kremlin-Bic\u00eatre, France"},{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou, Service de G\u00e9n\u00e9tique, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"key":"2025101800043696000_57.11.752.1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8493574"},{"key":"2025101800043696000_57.11.752.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13643-4"},{"key":"2025101800043696000_57.11.752.3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ejhg.2016.173","article-title":"Prevalence, birth incidence, and penetrance of von Hippel-Lindau disease (vHL) in Denmark","volume":"25","author":"Binderup","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"2025101800043696000_57.11.752.4","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2014.188"},{"key":"2025101800043696000_57.11.752.5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1301302"},{"key":"2025101800043696000_57.11.752.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.1484"},{"key":"2025101800043696000_57.11.752.7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jmoldx.2017.04.009","article-title":"PheoSeq: a targeted next-generation sequencing assay for pheochromocytoma and paraganglioma diagnostics","volume":"19","author":"Curr\u00e1s-Freixes","year":"2017","journal-title":"J Mol Diagn"},{"key":"2025101800043696000_57.11.752.8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-838235"},{"key":"2025101800043696000_57.11.752.9","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2010.175"},{"key":"2025101800043696000_57.11.752.10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.185","article-title":"Consensus statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","author":"Toledo","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"2025101800043696000_57.11.752.11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1498"},{"key":"2025101800043696000_57.11.752.12","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"2025101800043696000_57.11.752.13","first-page":"835","article-title":"Comparative evaluation of microsatellite marker, AP-PCR and CGH studies in primary renal cell carcinoma","volume":"13","author":"Hoefling","year":"2004","journal-title":"Int J Mol Med"},{"key":"2025101800043696000_57.11.752.14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF03036738","article-title":"Microsatellite analysis of chromosome 3p region in sporadic renal cell carcinomas","volume":"8","author":"Girolami","year":"2002","journal-title":"Pathol Oncol Res"},{"key":"2025101800043696000_57.11.752.15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41379-019-0343-4","article-title":"Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma-a retrospective and prospective study","volume":"33","author":"Favier","year":"2020","journal-title":"Mod Pathol"},{"key":"2025101800043696000_57.11.752.16","doi-asserted-by":"crossref","DOI":"10.1038\/srep21418","article-title":"Straightforward and sensitive RT-qPCR based gene expression analysis of FFPE samples","volume":"6","author":"Zeka","year":"2016","journal-title":"Sci Rep"},{"key":"2025101800043696000_57.11.752.17","doi-asserted-by":"crossref","DOI":"10.1186\/2046-2530-2-3","article-title":"Pancreatic cyst development: insights from von Hippel-Lindau disease","volume":"2","author":"van Asselt","year":"2013","journal-title":"Cilia"},{"key":"2025101800043696000_57.11.752.18","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.111316"},{"key":"2025101800043696000_57.11.752.19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.21.12596"},{"key":"2025101800043696000_57.11.752.20","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.538"},{"key":"2025101800043696000_57.11.752.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.03.015"},{"key":"2025101800043696000_57.11.752.22","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7044","article-title":"Multi-Omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas","volume":"6","author":"Castro-Vega","year":"2015","journal-title":"Nat Commun"},{"key":"2025101800043696000_57.11.752.23","doi-asserted-by":"publisher","DOI":"10.1210\/me.2010-0256"},{"key":"2025101800043696000_57.11.752.24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2535"},{"key":"2025101800043696000_57.11.752.25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1210\/jc.2017-01762","article-title":"Clinical aspects of SDHA-Related pheochromocytoma and paraganglioma: a nationwide study","volume":"103","author":"van der Tuin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2025101800043696000_57.11.752.26","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2010.153320"},{"key":"2025101800043696000_57.11.752.27","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2018-105714"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmedgenet-2019-106519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:04:43Z","timestamp":1760771083000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmedgenet-2019-106519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,10,23]]},"published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1136\/jmedgenet-2019-106519"],"URL":"https:\/\/doi.org\/10.1136\/jmedgenet-2019-106519","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,29]]}}}